Top

Supportive Care in Cancer

Published in:

01-02-2019 | Review Article

Sensory preferences of supplemented food products among cancer patients: a systematic review

Authors: Blanca E. Enriquez-Fernández, Sara Nejatinamini, Sandra M. Campbell, Vera C. Mazurak, Wendy V. Wismer

Published in: Supportive Care in Cancer | Issue 2/2019

Abstract

Purpose

Oral nutritional supplements and fortified foods, here considered supplemented food products (SFP), are recommended as part of nutrition therapy guidelines to treat malnutrition among cancer patients. However, their successful use is limited by patients’ failure to meet recommended intakes. This systematic review aimed to identify sensory preferences for SFP among cancer patients and evaluate the methodologies employed in sensory preference assessment.

Methods

A systematic search was conducted in several relevant databases yielding 1056 papers of which 19 met the inclusion criteria. Two authors independently selected papers and extracted findings. The included papers were categorized according to the focus of the preference assessment.

Results

Studies comparing sensory preferences for SFP of cancer patients with those of a control group suggested that the liking for SFP by cancer patients differs from healthy participants. Patient heterogeneity in site and stage of tumor, variation in study methodologies, and type of treatment complicated a conclusion regarding the effects of cancer treatment and taste changes on taste preferences. However, some general results were observed among the studies, such as the preference for fresh milk-based supplements when compared with other supplement types.

Conclusion

This review highlighted the need for consistent reporting and control of variables that influence the sensory characteristics of SFP when sensory preferences are assessed in the clinical setting. Attention to these methodological details will enhance the reliability and accuracy of sensory preference assessment among cancer patients for realistic evaluation of SFP targeted to their nutritional needs.

Available only for authorised users

Baldwin C, Weekes CE (2011) Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults. Cochrane Database Syst Rev :1465–1858

Van Cutsem E, Arends J (2005) The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9(Suppl 2):S51–S63CrossRef

Kubrak C, Jensen L (2007) Malnutrition in acute care patients: a narrative review. Int J Nurs Stud 44:1036–1054CrossRef

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hütterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Mühlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser J (2016) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36:11–48. https://doi.org/10.1016/j.clnu.2016.07.015 CrossRefPubMed

Thompson KL, Elliott L, Fuchs-Tarlovsky V, Levin RM, Voss AC, Piemonte T (2017) Oncology evidence-based nutrition practice guideline for adults. J Acad Nutr Diet 117:297–310. https://doi.org/10.1016/j.jand.2016.05.010 CrossRefPubMed

Fearon KCH, Von Meyenfeldt MF, AGW M, van Geenen R, Roy A, Gouma DJ, Giacosa A, van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52:1479–1486CrossRef

Ravasco P (2005) Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 9(Suppl 2):S84–S91CrossRef

Hutton JL, Martin L, Field CJ, Wismer WV, Bruera ED, Watanabe SM, Baracos VE (2006) Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy. Am J Clin Nutr 84:1163–1170CrossRef

Prado CMM, Lieffers JR, Bergsten G, Mourtzakis M, Baracos VE, Reiman T, Sawyer MB, McCargar LJ (2012) Dietary patterns of patients with advanced lung or colorectal cancer. Can J Diet Pract Res 73:e298–e303CrossRef

10.

McGreevy J, Orrevall Y, Belqaid K, Wismer W, Tishelman C, Bernhardson BM (2014) Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer. Support Care Cancer 22:2635–2644CrossRef

11.

Cohen J, Wakefield CE, Laing DG (2016) Smell and taste disorders resulting from cancer and chemotherapy. Curr Pharm Des 22:2253–2263CrossRef

12.

Rahemtulla Z, Baldwin C, Spiro A, McGough C, Norman AR, Frost G, Cunningham D, Andreyev HJN (2005) The palatability of milk-based and non-milk-based nutritional supplements in gastrointestinal cancer and the effect of chemotherapy. Clin Nutr 24:1029–1037CrossRef

13.

Brown A, England R, StJohn J, Taylor V, Manderson C, Halliday V, Wilcock A (2013) The liking and preferences of people with thoracic cancer for oral nutritional supplement drinks. ESpen Eur E J Clin Nutr Metab 8:e55–e58. https://doi.org/10.1016/j.clnme.2012.12.005 CrossRef

14.

Bolton J, Abbott R, Kiely M, Alleyne M, Bell S, Stubbs L, Slevin M (1992) Comparison of three oral sip-feed supplements in patients with cancer. J Hum Nutr Diet 5:79–84CrossRef

15.

Gosney M (2003) Are we wasting our money on food supplements in elder care wards? J Adv Nurs 43:275–280CrossRef

16.

IFT (1975) Minutes of division of business meeting

17.

Brown RO, Schlegel K, Hall NH, Bernard S, Heizer WD (1986) Taste preferences for nutritional supplements: comparison of cancer patients and healthy controls using a wine-tasting scale. J Parenter Enter Nutr 10:490–493. https://doi.org/10.1177/0148607186010005490 CrossRef

18.

Baik HW, Sung M, Lee YS, Song M, Bae YJ (2014) The palatability of cereal based nutritional supplements in cancer patients. Clin Nutr Res 3:48–55. https://doi.org/10.7762/cnr.2015.4.1.68 CrossRefPubMedPubMedCentral

19.

Cohen J, Rosen K, Russell KK, Wakefield CE, Goodenough B (2011) Paediatric oncology patient preference for oral nutritional supplements in a clinical setting. Support Care Cancer 19:1289–1296. https://doi.org/10.1007/s00520-010-0943-5 CrossRefPubMed

20.

De Luis DA, Cabezas G, Izaola O, Aller R, Cuellar L, Terroba MC (2007) Comparation of short term acceptability of three oral nutritional supplements. An Med Interna 24:15–18PubMed

21.

De Wyes WD, Herbst SH (1977) Oral feeding in the nutritional management of the cancer patient. Cancer Res 37:2429–2431PubMed

22.

Gallagher P, Tweedle DE (1983) Taste threshold and acceptability of commercial diets in cancer patients. J Parenter Enter Nutr 7:361–363. https://doi.org/10.1177/0148607183007004361 CrossRef

23.

Garofolo A, Alves FR, do Carmo Rezende MA (2010) Homemade oral supplements for patients with cancer: descriptive analysis. [Suplementos orais artesanais desenvolvidos para pacientes com cancer: analise descritiva]. Rev Nutr 23:523–533. https://doi.org/10.1590/S1415-52732010000400003 CrossRef

24.

Gómez-Candela C, Villarino Sanz M, Horrisberger A, Loria Kohen V, Bermejo LM, Zamora Auñón P (2011) Efficacy evaluation of an oral powder supplement enriched with eicosapentaenoic acid in cancer patients. Nutr Hosp 26:1385–1393PubMed

25.

Ijpma I, Renken RJ, Ter Horst GJ, Reyners AKL (2016) The palatability of oral nutritional supplements: before, during, and after chemotherapy. Support Care Cancer 24:4301–4308. https://doi.org/10.1007/s00520-016-3263-6 CrossRefPubMedPubMedCentral

26.

Martin L, Zarn D, Hansen AM, Wismer W, Mazurak V (2008) Food products as vehicles for n-3 fatty acid supplementation. Can J Diet Pract Res 69(4):203–207. https://doi.org/10.3148/69.4.2008.203 CrossRefPubMed

27.

McGough C, Baldwin C, Norman A, Frost G, Blake P, Tait D, Khoo V, Harrington K, Andreyev HJN (2006) Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy? Clin Nutr 25:109–116. https://doi.org/10.1016/j.clnu.2005.09.007 CrossRefPubMed

28.

Morris R, Hart K, Smith V, Shannon L, Bolton J, Abbott R, Alleyne M, Plant H, Slevin ML (1990) A comparison of the energy supplements polycal and duocal in cancer patients. J Hum Nutr Diet 3:171–176CrossRef

29.

Parkinson SA, Lewis J, Morris R, Allbright A, Plant H, Slevin ML (1987) Oral protein and energy supplements in cancer patients. Hum Nutr Appl Nutr 41:233–243CrossRef

30.

Petersen GB, Andersen JR (2015) Nutritional supplements: taste preferences in patients with malignant haematological disease during active treatment. JMED Res 2015:1–8. https://doi.org/10.5171/2015.175008 CrossRef

31.

Trinidade A, Martinelli K, Andreou Z, Kothari P (2012) Soft, fortified ice-cream for head and neck cancer patients: a useful first step in nutritional and swallowing difficulties associated with multi-modal management. Eur Arch Otorhinolaryngol 269:1257–1260. https://doi.org/10.1007/s00405-011-1769-6 CrossRefPubMed

32.

Bolton J, Shannon L, Smith V, Abbott R, Bell SJ, Stubbs L, Slevin ML (1990) Comparison of short-term and long-term palatability of six commercially available oral supplements. J Hum Nutr Diet 3:317–321CrossRef

33.

ASTM International (2009) Standard terminology relating to sensory evaluations of materials and products, E253-09a. STM International. Available from https://www.astm.org/DATABASE.CART/HISTORICAL/E253-09A.htm 2018

34.

Meilgaard MC, Civille GV, Carr BT (2016) Sensory evaluation techniques. CRC Press (Taylor & Francis Group), Boca Raton

35.

Lawless HT, Heymann H (2010) Sensory evaluation of food: principles and practices. Springer, New YorkCrossRef

36.

Boyce JM, Shone GR (2006) Effects of ageing on smell and taste. Postgrad Med J 82:239CrossRef

37.

Doty RL, Kamath V (2014) The influences of age on olfaction: a review. Front Psychol 5:20. https://doi.org/10.3389/fpsyg.2014.00020/full CrossRefPubMedPubMedCentral

38.

Bernhardson BM, Tishelman C, Rutqvist LE (2007) Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manag 34:403–412CrossRef

39.

Methven L, Rahelu K, Economou N, Kinneavy L, Ladbrooke-Davis L, Kennedy OB, Mottram DS, Gosney MA (2010) The effect of consumption volume on profile and liking of oral nutritional supplements of varied sweetness: sequential profiling and boredom tests. Food Qual Prefer 21:948–955. https://doi.org/10.1016/j.foodqual.2010.04.009 CrossRef

40.

Thomas A, van der Stelt AJ, Prokop J, Lawlor JB, Schlich P (2016) Alternating temporal dominance of sensations and liking scales during the intake of a full portion of an oral nutritional supplement. Food Qual Prefer 53:159–167. https://doi.org/10.1016/j.foodqual.2016.06.008 CrossRef

41.

Snyder DJ, Prescott J, Bartoshuk LM (2006) Modern psychophysics and the assessment of human oral sensation. Adv Otorhinolaryngol 63:221–241PubMed

42.

Wickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E, Potter C, Blendowski C (1999) Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 26:697–706PubMed

43.

Brisbois TD, de Kock IH, Watanabe SM, Mirhosseini M, Lamoureux DC, Chasen M, MacDonald N, Baracos VE, Wismer WV (2011) Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Ann Oncol 22:2086–2093. https://doi.org/10.1093/annonc/mdq727 CrossRefPubMed

44.

Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, Platek ME, Price W, Stewart M, Teknos TN, Moskowitz B (2015) The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer 67:339–353CrossRef

45.

Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30:785–792CrossRef

46.

International Organization for Standardization (2017) Standards catalogue. Available from https://www.iso.org/ics/67.240/x/. Accessed 23 Sept 2017

47.

Stone H, Sidel JL (2004) Sensory evaluation practices. Elsevier Academic Press, California

48.

Pimentel TC, Deliza R, Cruz A (2016) Sensory evaluation: sensory rating and scoring methods. In: Caballero B, Finglas PM, Toldra F (eds) Encyclopedia of food and health, 1st edn. Elsevier, New York, pp 744–750CrossRef

49.

Kemp SE, Hollowood T, Hort J (2009) Sensory evaluation. Wiley-Blackwell, ChichesterCrossRef

50.

Hubbard GP, Elia M, Holdoway A, Stratton RJ (2012) A systematic review of compliance to oral nutritional supplements. Clin Nutr 31:293–312. https://doi.org/10.1016/j.clnu.2011.11.020 CrossRefPubMed

Title: Sensory preferences of supplemented food products among cancer patients: a systematic review
Authors: Blanca E. Enriquez-Fernández
Sara Nejatinamini
Sandra M. Campbell
Vera C. Mazurak
Wendy V. Wismer
Publication date: 01-02-2019
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 2/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4458-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2019

The role of positive psychological changes in anxiety and depression of patients with ovarian tumors and their partners: an observational study from the population-based PROFILES registry

Quality of care in hospitalized cancer patients before and after implementation of a systematic prevention program for delirium: the DELTA exploratory trial

Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants

Hispanic breast cancer patients’ symptom experience and patient-physician communication during chemotherapy

Examining trajectories of anxiety in men with prostate cancer faced with complex treatment decisions

Content analysis of rehabilitation goals for patients following non-surgical head and neck cancer treatment

Keynote webinar | Spotlight on antibody–drug conjugates in cancer